tradingkey.logo

ENDRA Life Sciences Inc

NDRA

3.780USD

+0.680+21.94%
Close 04/23, 16:00ETQuotes delayed by 15 min
2.03MMarket Cap
LossP/E TTM

ENDRA Life Sciences Inc

3.780

+0.680+21.94%
More Details of ENDRA Life Sciences Inc Company
ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. It is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Company Info
Company codeNDRA
Company nameENDRA Life Sciences Inc
IPO dateJun 28, 2017
Founded at2007
CEOMr. Alexander Y. Tokman
Number of employees21
Security typeOrdinary Share
Fiscal year-endJun 28
Address3600 Green Ct Ste 350
CityANN ARBOR
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code48105-2440
Phone17343350468
Websitehttps://www.endrainc.com/
Company codeNDRA
IPO dateJun 28, 2017
Founded at2007
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
59.00
--
Mr. Michael Milos Thornton
Mr. Michael Milos Thornton
Chief Technology Officer
Chief Technology Officer
20.00
--
Mr. Alexander Y. Tokman
Mr. Alexander Y. Tokman
Chairman of the Board, Acting Chief Executive Officer
Chairman of the Board, Acting Chief Executive Officer
5.00
--
Mr. Michael John Harsh
Mr. Michael John Harsh
Independent Director
Independent Director
2.00
--
Mr. Louis J. Basenese
Mr. Louis J. Basenese
Independent Director
Independent Director
--
--
Ms. Yvonne Briggs
Ms. Yvonne Briggs
IR Contact Officer
IR Contact Officer
--
--
Mr. Richard Jacroux
Mr. Richard Jacroux
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Independent Director
Independent Director
59.00
--
Mr. Michael Milos Thornton
Mr. Michael Milos Thornton
Chief Technology Officer
Chief Technology Officer
20.00
--
Mr. Alexander Y. Tokman
Mr. Alexander Y. Tokman
Chairman of the Board, Acting Chief Executive Officer
Chairman of the Board, Acting Chief Executive Officer
5.00
--
Mr. Michael John Harsh
Mr. Michael John Harsh
Independent Director
Independent Director
2.00
--
Mr. Louis J. Basenese
Mr. Louis J. Basenese
Independent Director
Independent Director
--
--
Ms. Yvonne Briggs
Ms. Yvonne Briggs
IR Contact Officer
IR Contact Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Wed, Apr 2
Update time: Wed, Apr 2
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
S.H.N. Financial Investments Ltd
0.12%
UBS Financial Services, Inc.
0.02%
DiGiandomenico (Anthony)
0.01%
Other
99.85%
Shareholder Statistics
Shareholder
Proportion
S.H.N. Financial Investments Ltd
0.12%
UBS Financial Services, Inc.
0.02%
DiGiandomenico (Anthony)
0.01%
Other
99.85%
Type
Shareholder
Proportion
Corporation
0.12%
Investment Advisor
0.02%
Individual Investor
0.02%
Other
99.84%
Institutional Shareholding
Update time: Tue, Mar 4
Update time: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
37
889.00
0.16%
-4.90K
2024Q4
38
889.00
0.17%
-4.90K
2024Q3
39
6.39K
8.81%
+5.79K
2024Q2
39
2.03K
9.18%
+1.72K
2024Q1
33
352.00
9.94%
+101.00
2023Q4
35
276.00
9.44%
+68.00
2023Q3
37
286.00
9.99%
+78.00
2023Q2
39
314.00
10.85%
+151.00
2023Q1
45
248.00
13.69%
+49.00
2022Q4
54
249.00
13.75%
+17.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
S.H.N. Financial Investments Ltd
686.00
0.12%
+686.00
--
Jun 04, 2024
UBS Financial Services, Inc.
95.00
0.02%
+95.00
--
Dec 31, 2024
DiGiandomenico (Anthony)
59.00
0.01%
--
--
Mar 24, 2025
Thornton (Michael Milos)
20.00
0%
--
--
Mar 24, 2025
Morgan Stanley & Co. LLC
13.00
0%
-62.00
-82.67%
Dec 31, 2024
Tokman (Alexander Y)
5.00
0%
--
--
Mar 24, 2025
BofA Global Research (US)
4.00
0%
+4.00
--
Dec 31, 2024
Michelon (Francois Roger)
3.00
0%
--
--
Mar 24, 2025
Harsh (Michael John)
2.00
0%
--
--
Mar 24, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Nov 05, 2024
Merger
35<1
Nov 05, 2024
Merger
35<1
Nov 05, 2024
Merger
35<1
Nov 05, 2024
Merger
35<1
Aug 16, 2024
Merger
50<1
Aug 16, 2024
Merger
50<1
Date
Type
Ratio
Nov 05, 2024
Merger
35<1
Nov 05, 2024
Merger
35<1
Nov 05, 2024
Merger
35<1
Nov 05, 2024
Merger
35<1
Aug 16, 2024
Merger
50<1
Aug 16, 2024
Merger
50<1
Aug 16, 2024
Merger
50<1
Aug 16, 2024
Merger
50<1
Dec 06, 2022
Merger
20<1
Dec 06, 2022
Merger
20<1
View more